#ThinkSabio Latest News
(+7.4% pre) Telomir Pharmaceuticals (TELO) Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND
(+7.4% pre) Telomir Pharmaceuticals (TELO) Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND